Activest Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Hold
4,000
﹤0.01% 532
2026
Q1
$9.88K Hold
4,000
﹤0.01% 687
2025
Q4
$8.2K Hold
4,000
﹤0.01% 700
2025
Q3
$13.9K Hold
4,000
﹤0.01% 432
2025
Q2
$8.8K Hold
4,000
﹤0.01% 456
2025
Q1
$4.64K Hold
4,000
﹤0.01% 511
2024
Q4
$5.08K Hold
4,000
﹤0.01% 373
2024
Q3
$13.6K Hold
4,000
﹤0.01% 286
2024
Q2
$18.7K Buy
+4,000
New +$22.6K 0.01% 243

Other funds holding EDIT

Activest Wealth Management's EDIT Position: Q2 2026 in Review

Activest Wealth Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 4,000 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #532.

Activest Wealth Management first reported a position in EDIT in Q2 2024 and has held it in 9 quarters since. The position peaked at $18.7K in Q2 2024. 49 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Activest Wealth Management held 4,000 shares of Editas Medicine worth $13K as of Q2 2026.
  • Activest Wealth Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #532 holding.
  • Activest Wealth Management first reported a position in Editas Medicine in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Editas Medicine position peaked at $18.7K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.